8-K//Current report
AN2 Therapeutics, Inc. 8-K
Accession 0001193125-25-110019
$ANTXCIK 0001880438operating
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:27 PM ET
Size
179.1 KB
Accession
0001193125-25-110019
Documents
- 8-Kd116214d8k.htmPrimary
8-K
- EX-99.1d116214dex991.htm
EX-99.1
- EX-101.SCHantx-20250501.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABantx-20250501_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREantx-20250501_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-110019-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd116214d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001880438
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:27 PM ET
- Size
- 179.1 KB